Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Stefano Ballestri, Dante Romagnoli, Fabio Nascimbeni, Giampiero Francica & Amedeo Lonardo. (2015) Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert Review of Gastroenterology & Hepatology 9:5, pages 603-627.
Read now
Read now
Mohamed M Radwan, Basil M Radwan, Kalyana C Nandipati, William J Hunter$suffix/text()$suffix/text() & Devendra K Agrawal. (2013) Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Expert Review of Clinical Immunology 9:8, pages 727-738.
Read now
Read now
Luigi E Adinolfi, Luciano Restivo, Rosa Zampino, Amedeo Lonardo & Paola Loria. (2011) Metabolic alterations and chronic hepatitis C: treatment strategies. Expert Opinion on Pharmacotherapy 12:14, pages 2215-2234.
Read now
Read now
Amedeo Lonardo, Stefano Bellentani, Vlad Ratziu & Paola Loria. (2011) Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – death of a dogma from analysis of therapeutic studies?. Expert Review of Gastroenterology & Hepatology 5:2, pages 279-289.
Read now
Read now
Ann K Daly, Stefano Ballestri, Lucia Carulli, Paola Loria & Christopher P Day. (2011) Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 5:2, pages 253-263.
Read now
Read now
Articles from other publishers (14)
Fatemeh Dashti, Seyed Moayed Alavian, Amir Ali Sohrabpour, Sara Ebrahimi Mousavi, Seyed-Ali Keshavarz & Ahmad Esmaillzadeh. (2023) Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial. BMJ Open 13:4, pages e063988.
Crossref
Crossref
Naiade Silveira Almeida, Raquel Rocha, Claudineia Almeida de Souza, Ana Carolina Sirelli da Cruz, Bruna dos Reis Ribeiro, Luiza Valois Vieira, Carla Daltro, Rafael Silva, Manoel Sarno & Helma Pinchemel Cotrim. (2022) Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease. World Journal of Hepatology 14:8, pages 1643-1651.
Crossref
Crossref
Elena S. George, Ekavi N. Georgousopoulou, Duane D. Mellor, Christina Chrysohoou, Christos Pitsavos & Demosthenes B. Panagiotakos. (2022) Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002–2012). Nutrients 14:12, pages 2367.
Crossref
Crossref
Elena S. George, Anjana Reddy, Amanda J. Nicoll, Marno C. Ryan, Catherine Itsiopoulos, Gavin Abbott, Nathan A. Johnson, Siddharth Sood, Stuart K. Roberts & Audrey C. Tierney. (2022)
Impact of a Mediterranean diet on hepatic and metabolic outcomes in
non‐alcoholic
fatty liver disease: The
MEDINA
randomised controlled trial
. Liver International 42:6, pages 1308-1322.
Crossref
Crossref
Barbara R Cardoso, Sze-Yen Tan, Robin M Daly, Jack Dalla Via, Ekavi N Georgousopoulou & Elena S George. (2021) Intake of Nuts and Seeds Is Associated with a Lower Prevalence of Nonalcoholic Fatty Liver Disease in US Adults: Findings from 2005–2018 NHANES. The Journal of Nutrition 151:11, pages 3507-3515.
Crossref
Crossref
Nicole Power Guerra, Luisa Müller, Kristin Pilz, Annika Glatzel, Daniel Jenderny, Deborah Janowitz, Brigitte Vollmar & Angela Kuhla. (2020) Dietary-Induced Low-Grade Inflammation in the Liver. Biomedicines 8:12, pages 587.
Crossref
Crossref
Jun Ma, Jinfeng Feng & Xiang Zhou. (2020) Long non-coding RNA HAGLROS regulates lipid metabolism reprogramming in intrahepatic cholangiocarcinoma via the mTOR signaling pathway. Experimental and Molecular Pathology 115, pages 104466.
Crossref
Crossref
Alireza Ghaemi, Narjes Hosseini, Saeed Osati, Mohammad mehdi Naghizadeh, Azizallah dehghan, Elham Ehrampoush, Behnam Honarvar & Reza Homayounfar. (2018) Waist circumference is a mediator of dietary pattern in Non-alcoholic fatty liver disease. Scientific Reports 8:1.
Crossref
Crossref
Cristiane V Tovo, Sabrina A Fernandes, Caroline Buss & Angelo A de Mattos. (2017) Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review. World Journal of Hepatology 9:6, pages 326.
Crossref
Crossref
Elena S. Papamiltiadous, Stuart K. Roberts, Amanda J. Nicoll, Marno C. Ryan, Catherine Itsiopoulos, Agus Salim & Audrey C. Tierney. (2016) A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol. BMC Gastroenterology 16:1.
Crossref
Crossref
Amedeo Lonardo & Dante Romagnoli. (2016) Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test. Indian Journal of Medical Research 143:1, pages 4.
Crossref
Crossref
Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, Paul Angulo & Paola Loria. (2015) Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Digestive and Liver Disease 47:3, pages 181-190.
Crossref
Crossref
Bi-xia Huang, Ming-fan Zhu, Ting Wu, Jing-ya Zhou, Yan Liu, Xiao-lin Chen, Rui-fen Zhou, Li-jun Wang, Yu-ming Chen & Hui-lian Zhu. (2015) Neck Circumference, along with Other Anthropometric Indices, Has an Independent and Additional Contribution in Predicting Fatty Liver Disease. PLOS ONE 10:2, pages e0118071.
Crossref
Crossref
Marco Bertolotti. (2014) Nonalcoholic fatty liver disease and aging: Epidemiology to management. World Journal of Gastroenterology 20:39, pages 14185.
Crossref
Crossref